NFKB1 and breast carcinoma: S100A7 was also identified as an essential protein in breast cancer cells, especially in estrogen receptor α (ERα) negative cells, where the binding to RAGE leads to activation of extracellular signal-regulated kinase (ERK) and NF-κB signalling, resulting in tumour growth and enhanced metastasis [101].